Share information

More information at WSE website

Archive

Investor news

ASBIS RECOMMENDED A RECORD HIGH DIVIDEND FOR 2022
March 29, 2023
ASBIS RECOMMENDED A RECORD HIGH DIVIDEND FOR 2022
PRESS RELEASE - 29 March 2023. Limassol, Cyprus
ASBIS EXPANDS THE PORTFOLIO OF BIOTECHNOLOGICAL COMPANIES
March 28, 2023
ASBIS EXPANDS THE PORTFOLIO OF BIOTECHNOLOGICAL COMPANIES
PRESS RELEASE - 28 March 2023. Limassol, Cyprus

Investor contacts

Constantinos Tziamalis, IR Director
Tel: +357 25857188
Fax: +357 25857181 

Bartosz Basa, Investor Relations Advisor
Tel: +48691910760
b.basa@asbis.com  

More investors contacts

Archive

Current reports

Current report No 6/2023 / Raport bieżący nr 6/2023
March 29, 2023
Current report No 6/2023 / Raport bieżący nr 6/2023
The Board of Directors‘ recommendation on the final dividend for Y2022.
Current report No 5/2023 / Raport bieżący nr 5/2023
March 28, 2023
Current report No 5/2023 / Raport bieżący nr 5/2023
Investment in Theramir Ltd.
Archive

ASBIS Press-Releases

Argus Research updated Equity Research Report Coverage on ASBISC Enterprises PLC
March 08, 2023
Argus Research updated Equity Research Report Coverage on ASBISC ...
MORE INNOVATION INSIGHTS WITH ASBIS AND NVIDIA AT THE CLOUDFEST 2023
February 27, 2023
ASBIS, CloudFest
MORE INNOVATION INSIGHTS WITH ASBIS AND NVIDIA AT THE CLOUDFEST 2023

Investor calendar

Dates of publication of consolidated quarterly, half-year and annual reports in 2023:

  • for Q4 2022 - February 23rd, 2023
  • for 2022 - March 30th, 2023
  • for Q1 2023 - May 11th, 2023
  • for H1 2023 - August 10th, 2023
  • for Q3 2023 - November 9th, 2023

Annual General Shareholders Meeting:

  • May 4th, 2022

Interim dividend:

  • the dividend date - November 17th, 2022
  • the dividend payout date - December 1st, 2022

More information

This website uses "cookies" to give you the best, most relevant experience. Most computers have their browsers set to automatically accept the use of cookies. Therefore, by using this website and not changing your browser settings, you are deemed to indicate your consent to our use of these cookies and other technologies and accept the terms of ASBISC Enterprises PLC Cookies Policy. If you do not consent the use of cookies on this website, please either be sure to block or disable them changing your browser settings (explained here) or stop using the website. If you decide to block cookies, you may experience reduced functionality or be prevented from using the website completely.